Clinical Trial

Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated May 2, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to observe and evaluate the efficacy and safety of HRS-4642 combined with SHR-A2102 in the treatment of advanced solid tumors
Trial Details
NCT Number NCT06955390
Lead Sponsor Henan Cancer Hospital
Conditions Solid Tumors
Enrollment 32 participants
Start Date 2025-05-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-02